Trial
NCT00360867
An Open Label Treatment Extension Study of AMG 706
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Amgen
Collaborators
—
Condition
Solid Tumors
Intervention
AMG 706
Why stopped
Amgen decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-15